[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Novartis AG (NVS)

Novartis is partnering with Relation Therapeutics for AI-driven drug discovery in atopic diseases, with a deal worth up to $XXX billion. Meanwhile, Terns Pharmaceuticals' drug shows potential to challenge Novartis's blockbuster leukemia treatment.

### About Novartis AG
Novartis AG is a global pharmaceutical company focused on developing and manufacturing innovative medicines.  
Novartis AG uses the ticker $NVS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Novartis AG (NVS) social dominance hit XXXXX which is XXX% higher than it's daily average.
- Novartis AG (NVS) trading volume is up XXXXXX% from the previous week.
- Novartis AG (NVS) social dominance is up XXX% from the previous month.
- Novartis AG Price hit a 52-Week high of $XXXXXX for the hour
- Novartis AG Price hit an all time of $XXXXXX for the hour

### Price: $XXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/novartis/time-series/close.tsv)  
The stock price is experiencing downward pressure, likely due to Q3 earnings that missed expectations, despite the positive news of the Avidity Biosciences acquisition. The market may be weighing the substantial investment against current financial performance.  

24-Hour: XXXX%
7-Day: XXXX%
30-Day: XXXX%

1-Year High: $XXXXXX on 2025-12-03  
1-Year Low: $XXXXX on 2024-12-19  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/novartis/time-series/alt_rank.tsv)  
Novartis AG (NVS) is currently AltRank #253 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XXX  
X Month: XXX -XXX  
X Months: XXX +86  
X Year: XXX -XXX  
1-Year High: XXXXX on 2025-02-18  
1-Year Low: XX on 2025-11-21  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/novartis/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX no change  
X Month: XX +1  
X Months: XX -XX  
X Year: XX -XX  
1-Year High: XX on 2025-05-20  
1-Year Low: XX on 2025-01-09  
  
  
### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/novartis/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXXXX  
X Week: XXXXXXXXX -XX%  
X Month: XXXXXXXXXX +80%  
X Months: XXXXXXXXXX +168%  
X Year: XXXXXXXXXX +167%  
1-Year High: XXXXXXXXX on 2025-11-27  
1-Year Low: XXXXXX on 2025-01-07  

Engagements by network (24h):
News: XXX
Reddit: XXXXX
TikTok: XXXXXX
X: XXXXXX
YouTube: XXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/novartis/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXXXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXXX +34%  
X Year: XXXXXX +195%  
1-Year High: XXXXX on 2025-10-27  
1-Year Low: XXX on 2024-12-25  

Mentions by network (24h):
News: XX
Reddit: XXX
TikTok: XXX
X: XXXXX
YouTube: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/novartis/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXX +28%  
X Year: XXXXXX +190%  
1-Year High: XXX on 2025-10-27  
1-Year Low: XXX on 2024-12-25  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                                                            | Rank | Followers | Posts | Engagements |
| -------                                                                            | ---- | --------- | ----- | ----------- |
| [@GlobalStatsX](/creator/twitter/GlobalStatsX)                                     | X    | XXXXXX    | X     | XXXXX       |
| [@stats_feed](/creator/twitter/stats_feed)                                         | X    | XXXXXXXXX | X     | XXXXX       |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)                                     | X    | XXX       | XX    | XXXXX       |
| [@progresspotentialpossibilities](/creator/youtube/progresspotentialpossibilities) | X    | XXXXXX    | X     | XXXXX       |
| [@ValueSense_io](/creator/twitter/ValueSense_io)                                   | X    | XXXXXX    | X     | XXXXX       |
| [@grok](/creator/twitter/grok)                                                     | X    | XXXXXXXXX | XX    | XXX         |
| [@BentheFidler](/creator/twitter/BentheFidler)                                     | X    | XXXXX     | X     | XXX         |
| [@HealthPolicyW](/creator/twitter/HealthPolicyW)                                   | X    | XXXXXX    | X     | XXX         |
| [@jason_pontin](/creator/twitter/jason_pontin)                                     | X    | XXXXXX    | X     | XXX         |
| [@cashch](/creator/twitter/cashch)                                                 | XX   | XXXXXX    | X     | XXX         |

[View More](/list/creators/novartis/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/novartis/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% -X%  
X Months: XX% +6%  
X Year: XX% +4%  
1-Year High: XX% on 2025-10-26  
1-Year Low: XX% on 2025-11-26  

Most Supportive Themes:
- Acquisition of Avidity Biosciences: (70%) Novartis AG is acquiring Avidity Biosciences for $XX billion, strengthening its neuroscience pipeline.
- Pipeline Advancements: (10%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
- Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.
  
Most Critical Themes:
- Drug Pricing and Access Concerns: (60%) There are discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
- Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.066%  
X Month: XXXXX% +0.146%  
X Months: XXXXX% +0.138%  
X Year: XXXXX% +0.136%  
1-Year High: XXXXX% on 2025-12-10  
1-Year Low: XXXXX% on 2025-07-01  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXX% on 2025-03-31  
1-Year Low: XXXXX% on 2024-12-16  
  
  
### Market Cap: $XXXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXXX -$0.94%  
X Month: $XXXXXXXXXXXXXXX +$3.70%  
X Months: $XXXXXXXXXXXXXXX +$5.40%  
X Year: $XXXXXXXXXXXXXXX +$24%  
1-Year High: $XXXXXXXXXXXXXXX on 2025-12-03  
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19  

### Top Novartis AG News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Mirum Therapeutics to buy Bluejay Therapeutics for up to $820M - San Francisco Business Times"  
[News Link](https://www.bizjournals.com/sanfrancisco/news/2025/12/09/mirum-bluejay-merger-novartis.html) [@bizjournals](/creator/x/bizjournals) 2025-12-10T01:05Z 228.6M followers, XXX engagements


"Notable analyst calls this week: Novartis Albemarle and Zscaler among top picks Seeking Alpha"  
[News Link](https://seekingalpha.com/news/4529036-notable-analyst-calls-this-week-novartis-albemarle-and-zscaler-among-top-picks) [@SeekingAlpha](/creator/x/SeekingAlpha) 2025-12-06T17:30Z 228.6M followers, 1877 engagements



### Top Novartis AG Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Switzerland - Equity Highlights Most Active: - $ROG / Roche Holding AG - Neutral (+31 Trending Higher) - $NOVN / Novartis AG - Favourable (+25 Trending Higher) - $NESN / Nestle SA - Unfavourable (0 Trending Lower) Best Darwin Scores: - $ZURN / Zurich Insurance Group AG - Favourable (+45 Trending Higher) - $EFGN / EFG International AG - Favourable (+39 Trending Higher) - $VACN / VAT Group AG - Favourable (+38 Trending Higher) Worst Darwin Scores: - $LONN / Lonza Group AG - Favourable (-10 Rangebound) - $SIKA / Sika AG - Favourable (-9 Rangebound) - $STMN / Straumann Holding AG - Favourable (-2"  
[X Link](https://x.com/Darwin_Knows/status/1998605104283541637) [@Darwin_Knows](/creator/x/Darwin_Knows) 2025-12-10T04:06Z XXX followers, XX engagements


"Noticed that the 15th Court denied Novartis motion to stay under Rule XXXXX. Under the new framework for stays the Court considers the likelihood of success on the merits (the standard was murky in Texas before). So it seems 15th Court is skeptical of the challenge to qui tam"  
[X Link](https://x.com/adam_shniderman/status/1998588423758921740) [@adam_shniderman](/creator/x/adam_shniderman) 2025-12-10T02:59Z 3824 followers, XXX engagements


"This hepatitis drug was cast off by Novartis. Now it's the center of a potential $XXX million deal between two Peninsula companies"  
[X Link](https://x.com/SFBusinessTimes/status/1998559589202121068) [@SFBusinessTimes](/creator/x/SFBusinessTimes) 2025-12-10T01:05Z 43.9K followers, XXX engagements


"No public statements found from these companies/CEOs on fenbendazole or ivermectin for cancer (verified via official sites 2023-2025). They focus on patented oncology drugs like: - Merck: Keytruda - BMS: Opdivo - AstraZeneca: Tagrisso Imfinzi (Vaxzevria pushed for COVID with noted clot risks) - Pfizer: Ibrance Xtandi - Roche: Tecentriq - Novartis: Kisqali Pluvicto These generate high revenues per 2025 reports"  
[X Link](https://x.com/grok/status/1998537770898534752) [@grok](/creator/x/grok) 2025-12-09T23:38Z 6.8M followers, XXX engagements